Gala vs Sipra
Gala and Sipra both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sipra
Best for: people ready to prepay three months or more for compounded semaglutide or tirzepatide
Visit Sipra →If you are choosing between Gala and Sipra, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 7.6.
Gala vs Sipra price
Gala and Sipra start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide is cheaper at Sipra ($149 a month on a prepaid plan vs $179 a month); tirzepatide is cheaper at Gala ($149 a month vs $199 a month on a prepaid plan).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Gala prices compounded injections and brand-name pens, while Sipra prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.
Where each one treats patients
Gala lists 50 states, and Sipra does not publish where it ships.
Pricing
Gala
$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.
$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.
$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'
'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).
Sipra
$189 a month on the shortest plan published, billed as one $567 payment. The same table lists $169 a month on a 6-month plan ($1,014) and $149 on a 12-month plan ($1,788). No 1-month price is published.
$249 a month on the 3-month plan, one $747 payment. $219 a month on 6 months ($1,314) and $199 on 12 months ($2,388).
Low-dose semaglutide plan: $149 a month for 3 months, $129 for 6 and $119 for 12.
Low-dose tirzepatide plan: $199 a month for 3 months, $179 for 6 and $159 for 12.
Sold as SemaMelt. $249 a month for 3 months, $219 for 6 and $199 for 12.
Sold as TirzaMelt. $269 a month for 3 months, $249 for 6 and $239 for 12.
What each price covers
Both prices cover the clinician visit, the medication itself and shipping.
Gala is silent on lab work and coaching.
Sipra is silent on lab work and coaching.
Gala
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Sipra
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Gala scores 8.7 and Sipra 7.6 out of 10.
Gala is stronger on value (8.7 vs 6.7), trust & safety (7.5 vs 6.5) and accessibility (10.0 vs 5.0).
Effectiveness, user experience and support are within half a point.
Gala
8.7/10
Sipra
7.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Gala nor Sipra has an FDA warning letter on record with us.
Features & Coverage
| Feature | Gala | Sipra |
|---|---|---|
| Starting Price | $149/mo | $149/mo prepaid |
| Features | 7 features | ✓8 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warning Letters | None | None |
About Gala
A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.
Read our full Gala review →About Sipra
Sipra is a Wyoming-registered telehealth platform whose prescribing runs through the MD Integrations physician network. It sells compounded semaglutide and tirzepatide as B12-blended weekly injections, dissolving tablets and microdose plans. Plans start at three months, paid upfront: semaglutide injections are $189 a month ($567) and tirzepatide $249 ($747), falling to $149 and $199 on a 12-month plan. You are charged only after a physician approves.
Read our full Sipra review →Pros & Cons
Gala
What we like
- Semaglutide costs $179 a month, close to the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Gala
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Sipra
What we like
- Semaglutide costs $149 a month, 21% below the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Sipra
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Gala wins this one, 8.7 to 7.6, above all for moving between compounded and brand without changing seller. Sipra fits better if people ready to prepay three months or more for compounded semaglutide or tirzepatide is your priority.
Choose Gala if…
You want moving between compounded and brand without changing seller and an opening price near $149 a month.
Choose Sipra if…
You want people ready to prepay three months or more for compounded semaglutide or tirzepatide and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →Gala vs Sipra: FAQ
Close alternatives to Gala and Sipra
- Gala vs altRX
- Gala vs Sprout Health
- Gala vs Aquivia Health
- Gala vs Vytora Health
- Sipra vs altRX
- Sipra vs Trinity Meds
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.